Content-Length: 61247 | pFad | http://web.archive.org/web/20160811231214/http://www.medscape.com/viewcollection/33812

American Society of Retina Specialists (ASRS) 2016 Annual Meeting

Edition: English Deutsch Español Français Português

Multispecialty

News & Perspective

Drugs & Diseases

CME & Education

From Medscape Ophthalmology

American Society of Retina Specialists (ASRS) 2016 Annual Meeting

August 09 - 14, 2016; San Francisco, California

August 09 - 14, 2016 San Francisco, California

ASRS Vancomycin in Cataract Procedures May Cause Blindness Researchers have documented 35 eyes with severe hemorrhagic occlusive retinal vasculitis after treatment with vancomycin during cataract procedures.
Medscape Medical News, August 15, 2016
ASRS New Batches of Ranibizumab Biosimilar Safe, Effective Razumab, an Indian biosimilar for ranibizumab, appears to have overcome the high incidence of inflammation with a new manufacturing process, report investigators.
Medscape Medical News, August 15, 2016
Genes May Shape Supplements' Effect on Macular Degeneration Two new studies have reignited the controversy over the relationship of genes to the AREDS formulation of supplements being marketed to slow macular degeneration.
Medscape Medical News, August 10, 2016

Conference News

ASRS Vancomycin in Cataract Procedures May Cause Blindness
Medscape Medical News, August 15, 2016
ASRS New Batches of Ranibizumab Biosimilar Safe, Effective
Medscape Medical News, August 15, 2016
ASRS Real-World Anti-VEGF Data Disappointing
Medscape Medical News, August 11, 2016

Genes May Shape Supplements' Effect on Macular Degeneration
Medscape Medical News, August 10, 2016
ASRS Retina Treatment Adverse Events to Take Center Stage at ASRS
Medscape Medical News, August 5, 2016

Popular News from ASRS 2015

Aspirin Benefits Outweigh Risks in Macular Degeneration Early evidence had suggested a heightened risk for macular degeneration, but a new analysis has suggested the consequences of stopping aspirin may be dire.
Medscape Medical News, Jul 16, 2015
Drug Dosages Questioned in Diabetic Macular Edema Trial Experts wonder whether increased doses might eliminate the advantages seen with aflibercept over bevacizumab and ranibizumab in a diabetic macular edema trial.
Medscape Medical News, Jul 17, 2015
Novel Microinjection Promising for Macular Degeneration Microinjections of the experimental drug RTH258 can be used to effectively treat age-related macular degeneration, early results suggest.
Medscape Medical News, Jul 16, 2015

Medscape Ophthalmology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Medscape Board at the Podium

David Brown, MD
Baylor College of Medicine, Houston, Texas
Presentation: AMD Neovascular 1 Symposium
Date: August 10, 2016
Presentation: Symposium: Clinical Trials Unplugged: Real, Practical Questions and Answers
Date: August 11, 2016

Previous Coverage

Related Resource

AMD and Retinal Disease News & Perspectives

All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.